AJ Cooper, LV Sequist, JJ Lin - Nature reviews. Clinical oncology, 2022 - ncbi.nlm.nih.gov
The discoveries of EGFR mutations and ALK rearrangements as actionable oncogenic
drivers in non-small-cell lung cancer (NSCLC) has propelled a biomarker-directed treatment …